GS
ELV icon

GTS Securities’s Elevance Health ELV Stock Holding History

GTS Securities’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,400
Closed -$13.7M – 2105
2024
Q3 		$13.7M Buy
26,400
+1,100
+4% +$588K 0.03% 383
2024
Q2 		$13.7M Buy
25,300
+1,500
+6% +$793K 0.03% 377
2024
Q1 		$12.3M Sell
23,800
-8,700
-27% -$4.33M 0.02% 425
2023
Q4 		$15.3M Sell
32,500
-6,500
-17% -$3.01M 0.03% 428
2023
Q3 		$17M Buy
+39,000
New +$17.7M 0.03% 385

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GTS Securities's ELV Position: Q2 2026 in Review

GTS Securities reduced its Elevance Health (ELV) stake by 40% in Q2 2026, selling an estimated $145K and leaving 584 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

GTS Securities first reported a position in ELV in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.08M in Q4 2023. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • GTS Securities held 584 shares of Elevance Health worth $226K as of Q2 2026.
  • GTS Securities sold 391 Elevance Health shares in Q2 2026, an estimated $145K.
  • Elevance Health made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1142 holding.
  • GTS Securities first reported a position in Elevance Health in Q3 2023 and has held it in 11 quarters since.
  • GTS Securities's Elevance Health position peaked at $2.08M in Q4 2023.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.